Most epidemiologic studies of prostate cancer have focused on the genes involved in the steroidogenic pathway, such as P450 cytochrome 3A4 (CYP3A4), CYP17, and SRD5A2. This evidence concerns the gene CYP3A4 and prostate cancer.